High-impact clinical trials yield results tha

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2023 November 1–November 5.

Related Keywords

Philadelphia ,Pennsylvania ,United States ,France ,Netherlands ,Canada ,Groningen ,Monaco ,Tokyo ,Japan ,Dan Brennan ,Katheriner Tuttle ,Patrick Rossignol ,Michelle Rheault ,Hiddo Lambers Heerspink ,Tadao Akizawa ,Brad Rovin ,Amit Garg ,University Of Minnesota Medical School ,Showa University School Of Medicine ,University Of Lorraine ,London Health Sciences Centre Research Institute ,Drug Administration ,University Medical Center Groningen ,University Of Washington ,Ohio State University ,Ohio State ,Pivotal Results ,Minnesota Medical ,Focal Segmental Glomerulosclerosis ,Showa University School ,Placebo Controlled Phase ,Bardoxolone Methyl ,Diabetic Kidney Disease ,Aldosterone Synthase Inhibition ,Without Background Sodium Glucose Cotransporter ,Dapagliflozin Alone ,Interventional Survival Trial ,Princess Grace Hospital ,Antagonist Chronic ,Primary Results ,Western University ,Multi Component Intervention ,Improve Patient Access ,Kidney Transplantation ,Living Kidney ,Medeor Therapeutics ,Chief Medical Officer Dan Brennan ,Operational Immune Tolerance Achieved ,Living Related ,Matched Kidney Transplant ,